Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-385268

Eikon Therapeutics, Inc. · EIKN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Tim Kutzkey
10% Owner
Period of report
Sep 3, 2026
Accepted (ET)
Sep 8, 2026 · 4:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001861123

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Sep 3, 2026P89,200$11.5588A89,200ISee footnote
Common StockF3holding———4,312,139IBy The Column Group IV, LP
Common StockF4holding———148,840IBy The Column Group IV-A, LP
Common StockF5holding———1,319,164IBy The Column Group Opportunity III, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses